These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36871138)

  • 21. Evaluating and improving real-world evidence with Targeted Learning.
    Gruber S; Phillips RV; Lee H; Concato J; van der Laan M
    BMC Med Res Methodol; 2023 Aug; 23(1):178. PubMed ID: 37533017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making.
    Franklin JM; Glynn RJ; Martin D; Schneeweiss S
    Clin Pharmacol Ther; 2019 Apr; 105(4):867-877. PubMed ID: 30636285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Evaluation of the Algorithm CErtaInty Tool (ACE-IT) to Assess Electronic Medical Record and Claims-based Algorithms' Fit for Purpose for Safety Outcomes.
    Singh S; Beyrer J; Zhou X; Swerdel J; Harvey RA; Hornbuckle K; Russo L; Ghauri K; Abi-Elias IH; Cox JS; Rodriguez-Watson C
    Drug Saf; 2023 Jan; 46(1):87-97. PubMed ID: 36396894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replication of Randomized, Controlled Trials Using Real-World Data: What Could Go Wrong?
    Thompson D
    Value Health; 2021 Jan; 24(1):112-115. PubMed ID: 33431143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of real-world data and evidence for medical devices: a qualitative study of key informant interviews.
    Polisena J; Jayaraman G
    Int J Technol Assess Health Care; 2020 Dec; 36(6):579-584. PubMed ID: 33161916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Observational designs for real-world evidence studies.
    Taur SR
    Perspect Clin Res; 2022; 13(1):12-16. PubMed ID: 35198423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid clinical trials to generate real-world evidence: design considerations from a sponsor's perspective.
    Zhu M; Sridhar S; Hollingsworth R; Chit A; Kimball T; Murmello K; Greenberg M; Gurunathan S; Chen J
    Contemp Clin Trials; 2020 Jul; 94():105856. PubMed ID: 31669449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-World Evidence: A Primer.
    Dang A
    Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making.
    Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Mullins CD
    Value Health; 2017 Sep; 20(8):1003-1008. PubMed ID: 28964430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When Can We Trust Real-World Data To Evaluate New Medical Treatments?
    Simon GE; Bindman AB; Dreyer NA; Platt R; Watanabe JH; Horberg M; Hernandez A; Califf RM
    Clin Pharmacol Ther; 2022 Jan; 111(1):24-29. PubMed ID: 33932030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
    Wu J; Wang C; Toh S; Pisa FE; Bauer L
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions.
    Sheffield KM; Dreyer NA; Murray JF; Faries DE; Klopchin MN
    J Comp Eff Res; 2020 Oct; 9(15):1043-1050. PubMed ID: 32914653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.
    Chan K; Nam S; Evans B; de Oliveira C; Chambers A; Gavura S; Hoch J; Mercer RE; Dai WF; Beca J; Tadrous M; Isaranuwatchai W
    BMJ Open; 2020 Jan; 10(1):e032884. PubMed ID: 31915169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analyses using real-world data to generate clinical and epidemiological evidence: a systematic literature review of existing recommendations.
    Briere JB; Bowrin K; Taieb V; Millier A; Toumi M; Coleman C
    Curr Med Res Opin; 2018 Dec; 34(12):2125-2130. PubMed ID: 30217138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world evidence and product development: Opportunities, challenges and risk mitigation.
    Naidoo P; Bouharati C; Rambiritch V; Jose N; Karamchand S; Chilton R; Leisegang R
    Wien Klin Wochenschr; 2021 Aug; 133(15-16):840-846. PubMed ID: 33837463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.
    Wang SV; Schneeweiss S; Berger ML; Brown J; de Vries F; Douglas I; Gagne JJ; Gini R; Klungel O; Mullins CD; Nguyen MD; Rassen JA; Smeeth L; Sturkenboom M;
    Value Health; 2017 Sep; 20(8):1009-1022. PubMed ID: 28964431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-World Evidence for Regulatory Decision-Making: Guidance From Around the World.
    Burns L; Roux NL; Kalesnik-Orszulak R; Christian J; Hukkelhoven M; Rockhold F; O'Donnell J
    Clin Ther; 2022 Mar; 44(3):420-437. PubMed ID: 35181179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and Content of a Taxonomy to Support the Use of Real-World Evidence by Health Technology Assessment Practitioners and Healthcare Decision Makers.
    Murphy LA; Akehurst R; Solà-Morales O; Cunningham D; Mestre-Ferrandiz J; Franklin M; de Pouvourville G
    Value Health; 2023 Apr; 26(4S):20-31. PubMed ID: 36706951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design.
    Xia AD; Schaefer CP; Szende A; Jahn E; Hirst MJ
    Drugs Real World Outcomes; 2019 Dec; 6(4):193-203. PubMed ID: 31741199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?
    Malone DC; Brown M; Hurwitz JT; Peters L; Graff JS
    Value Health; 2018 Mar; 21(3):326-333. PubMed ID: 29566840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.